Fundz

Oxford Cancer Analytics Grabs £1.27M To Revolutonise Lung Cancer Management

PRIVATESep 06, 2021

Amount Raised

£1.27 Million

Round Type

Seed

OxfordBiotechnologyHealth CareArtificial IntelligenceHealth Diagnostics

Description

In the UK, it is reported that nearly 130 people are diagnosed with lung cancer every day. An early diagnosis will give a 57 per cent chance of survival for more than five years as compared to diagnosing at a later stage, wherein the survival rate is a meagre 3 per cent. This is where Oxcan (Oxford Cancer Analytics) comes to play as it strives to identify more cases in the early stage.

Quick answer

Oxford Cancer Analytics raised £1.27 Million in a Seed round, dated September 6, 2021. Oxford Cancer Analytics is based in Oxford, England, United Kingdom.

How much did Oxford Cancer Analytics raise?
Oxford Cancer Analytics raised £1.27 Million in a Seed round on September 6, 2021.
What does Oxford Cancer Analytics do?
Oxford Cancer Analytics Ltd (OXcan) is on a mission to enable curative cancer treatments through early detection.
Where is Oxford Cancer Analytics based and how big is it?
Oxford Cancer Analytics is based in Oxford, England, United Kingdom. Fundz records about 15 employees.
Who are the decision-makers at Oxford Cancer Analytics?
Fundz holds 4 contacts at Oxford Cancer Analytics, including the CEO and Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Health Diagnostics and Biotechnology around the same time

Companies in the same sectors as Oxford Cancer Analytics that raised within 45 days of this round, from Fundz verified event records.

  • Blackford Analysis raised $687K (Seed) on August 20, 2021.
  • Envisagenics raised $19M on October 19, 2021.
  • WaveFront Dynamics Inc. raised $700K (Seed) on October 14, 2021.
  • Exscientia raised $510M (Post-IPO Equity) on October 5, 2021.
  • Envisagenics raised an undisclosed amount (Series A) on September 29, 2021.
  • Prospection raised $45M (Funding Round) on September 14, 2021.

Who to call at Oxford Cancer Analytics, and when

A new round usually means Oxford Cancer Analytics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Oxford Cancer Analytics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Oxford Cancer Analytics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Oxford Cancer Analytics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Oxford Cancer Analytics

Location

Oxford, England, United Kingdom

About

Oxford Cancer Analytics Ltd (OXcan) is on a mission to enable curative cancer treatments through early detection. OXcan's machine learning platform enables minimally invasive and inexpensive cancer screening in high risk populations through analysing cancer materials shed into the blood. OXcan hopes to create a paradigm shift in screening and eventually replacing invasive tissue biopsy and expensive, complex imaging as the current standard of care. It is safer, cheaper, and detects cancers much earlier, when they are still curable.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Oxford Cancer Analytics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsPeter L., CEO and Co-Founder hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Oxford Cancer Analytics's next move

See what Strategic adds

Oxford Cancer Analytics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.